CEREHA ( Site 0004)

Sarandí, Buenos Aires B1872JBA

0 studies enrolling now · 1 studies all time

What they study most

End-Stage Kidney Disease, End-Stage Renal Disease, Kidney Failure, Chronic

Studies at this site

• Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007) — Completed